Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data (Q30580986)

25 June 2017

1 reference

title

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data (English)

1 reference

25 June 2017

Christopher G. Parsons

1 reference

ORCID Public Data File 2021

Wojciech Danysz

series ordinal

2

object named as

Danysz W

1 reference

25 June 2017

Parsons CG

1

1 reference

PubMed ID

10465680

25 June 2017

Quack G

series ordinal

3

1 reference

25 June 2017

1 June 1999

1 reference

25 June 2017

1 reference

25 June 2017

38

1 reference

25 June 2017

735-767

1 reference

25 June 2017

6

1 reference

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

25 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Changes in extracellular amino acids and spontaneous neuronal activity during ischemia and extended reflow in the CA1 of the rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Anticonvulsant effects of memantine and MK-801 in guinea pig hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

A mouse model of focal cerebral ischemia for screening neuroprotective drug effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Opposite effects of GABAA and NMDA receptor antagonists on ethanol-induced behavioral sleep in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Aminooxy-analogues of spermidine: new partial agonists and antagonists at the polyamine site of the rat hippocampal NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Study on the role of glycine, strychnine-insensitive receptors (glycineB sites) in the discriminative stimulus effects of ethanol in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Study of potency, kinetics of block and toxicity of NMDA receptor antagonists using fura-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Trapping channel block of NMDA-activated responses by amantadine and memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine reduces functional and morphological consequences induced by global ischemia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The b-wave of the electroretinogram as an index of retinal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Staging of Alzheimer-related cortical destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Different binding affinities of NMDA receptor channel blockers in various brain regions—Indication of NMDA receptor heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Chronic treatment with the uncompetitive NMDA receptor antagonist memantine influences the polyamine and glycine binding sites of the NMDA receptor complex in aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

7 January 2021

Neuroactive amino acids in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Free radical mechanisms in schizophrenia and tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Antagonists of the NMDA receptor-channel complex and motor coordination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The time course of glutamate in the synaptic cleft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Low-frequency activation of the NMDA receptor system can prevent the induction of LTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Excitatory amino acid receptors and synaptic plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Neuroleptic antagonism of dyskinetic phenomena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Excitotoxic Mechanisms May Be Involved in the Pathophysiology of Tardive Dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The antiseizure efficacies of MK-801, phencyclidine, ketamine, and memantine are altered selectively by stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

A cure for wind up: NMDA receptor antagonists as potential analgesics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Pharmacological activity of amantadine: effect of N-alkyl substitution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Determination of intracellular Ca2+ concentration can be a useful tool to predict neuronal damage and neuroprotective properties of drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Structural determinants of the blocker binding site in glutamate and NMDA receptor channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effect of psychotropic agents on a model of absence epilepsy in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Excitotoxic index — a biochemical marker of selective vulnerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Glutamate transmission and toxicity in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The effect of dimethylaminoadamantane on neuronal membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Prevention and antagonism of acute carbofuran intoxication by memantine and atropine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Evidence for alcohol anti-craving properties of memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Evidence for lysosomotropism of memantine in cultured human cells: cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and beta-adrenergic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Ethanol and N -methyl- D -aspartate receptor complex interactions: a detailed drug discrimination study in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Low concentrations of N-methyl-D-aspartate inhibit the induction of long-term potentiation in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Membrane properties and synaptic responses of rat striatal neurones in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine prevents quinolinic acid-induced hippocampal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Transient expression of NMDA receptors during rearrangement of AMPA-receptor-expressing fibers in the developing inner ear.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Affinity of 1-aminoadamantanes for the σ binding site in post-mortem human frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Ethanol discrimination in the rat: lack of modulation by restraint stress and memantine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Apparent independent action of nimodipine and glutamate antagonists to protect cultured neurons against glutamate-induced damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine prevents HIV coat protein-induced neuronal injury in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Over-additive anticonvulsant effect of memantine and NBQX in kindled rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Dopamine agonists and interaction with other neurotransmitter systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of memantine on the frog neuromuscular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effect of amantadine on chlorpromazine and reserpine-induced behavioral depression in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Selective loss of binding sites for the glutamate receptor ligands [3H]kainate and (S)-[3H]5-fluorowillardiine in the brains of rats with acute liver failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Learning deficits induced by chronic intraventricular infusion of quinolinic acid--protection by MK-801 and memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Selective vulnerability of hippocampal CA1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil: brain microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

MK-801 and memantine inhibit a centrally induced increase in myocardial oxygen demand in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

NMDA receptor antagonists can enhance or impair learning performance in animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Potential antidepressive properties of amantadine, memantine and bifemelane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The depression of monosynaptically excited alpha-motoneurons during vibration reflex by dimethylaminoadamantan (DMAA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Interaction of prion protein mRNA with CBP35 and other cellular proteins: possible implications for prion replication and age-dependent changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Striatal NMDA receptor subtypes: the pharmacology of N-methyl-D-aspartate-evoked dopamine, gamma-aminobutyric acid, acetylcholine and spermidine release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

NMDA receptor subtype selectivity: eliprodil, polyamine spider toxins, dextromethorphan, and desipramine selectively block NMDA-evoked striatal acetylcholine but not spermidine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Molecular analysis of excitatory amino acid receptor expression in the cochlea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Trends in the pathophysiology and pharmacotherapy of spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Magnesium gates glutamate-activated channels in mouse central neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Glutamate in CNS disorders as a target for drug development: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neurones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Characterisation of the glycine modulatory site of the N-methyl-D-aspartate receptor-ionophore complex in human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Chemical synaptic transmission in the cochlea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Synaptic repair mechanisms responsible for functional recovery in various cochlear pathologies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine (1-amino-3,5-dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a mutant hamster model of paroxysmal dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Pharmacotoxic psychosis after memantine in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Block of the N-methyl-D-aspartate receptor by phencyclidine-like drugs is influenced by alternative splicing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Suppression by memantine and amantadine of synaptic excitation intrastriatally evoked in rat neostriatal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Susceptibility of Primary Human Glial Fibrillary Acidic Protein-Positive Brain Cells to Human Immunodeficiency Virus Infection In Vitro: Anti-HIV Activity of Memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Behavioural pharmacology of glutamate receptors in the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Anticataleptic potencies of glutamate-antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The NMDA antagonist memantine impairs classical eyeblink conditioning in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The use of diurnal vigilance changes in the EEG to verify vigilance-enhancing effects of memantine in a clinical pharmacological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of memantine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

N-methyl-D-aspartate and alpha 2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Neuroprotective effect of memantine demonstrated in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The reduction of excitability of the gamma-loop by 1,3-dimethyl-5-aminoadamantane (DMAA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat--a pharmacokinetic microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Drug therapy for acquired pendular nystagmus in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Regionally different effects of scopolamine on NMDA antagonist-induced heat shock protein HSP70.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine induces heat shock protein HSP70 in the posterior cingulate cortex, retrosplenial cortex and dentate gyrus of rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Excitatory amino acids: implications for psychiatric disorders research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Effects of memantine on the twitch tension of mouse diaphragm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Amantadine in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Interaction of memantine with cholecystokinin receptors in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

MK-801 and memantine protect cultured neurons from glutamate toxicity induced by glutamate carboxypeptidase-mediated cleavage of methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

5-hydroxytryptamine and adenine uptake by human blood platelets following the release reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Infusion of (+) -MK-801 and memantine -- contrasting effects on radial maze learning in rats with entorhinal cortex lesion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

Dopaminergic stimulation enhances the utilization of noradrenaline in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

7 January 2021

Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

7 January 2021

Elevated NMDA receptors in parkinsonian striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

1 reference

7 January 2021

Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900019-2

7 January 2021

10.1016/S0028-3908(99)00019-2

Identifiers

DOI

1 reference

25 June 2017

1 reference

PubMed ID

10465680